Delivery Order SPE2DB24D2018-SPE2DB25FWSJ3

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,143.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,824,965 units of Duloxetine HCL DR 60 MG capsules. This is a Firm Fixed Price Delivery Order contract with a completion date of January 3, 2025. The award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of 4,564,428,298 units of Duloxetine HCL DR 60 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract, valued at $2,025.21, is a Delivery Order under Amerisourcebergen's Indefinite Delivery...
This federal contract award is a delivery order issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,215.82 firm fixed-price contract is for the delivery of 4,566,516,150 units of Duloxetine HCL DR 40 MG capsules. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. No set-aside designation was used for this award....
This is a delivery order award to AmerisourceBergen Drug Corp under a Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The order is for 4,565,240,669 units of Duloxetine HCl DR 40 mg capsules, with a ceiling value of $4,065.46. The contract has a firm fixed-price pricing type and an ultimate completion date of July 25, 2024. This order does not have a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen has a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $9,244.48 firm fixed price delivery order is for the supply of 4,564,097,792 units of Duloxetine Hydrochloride delayed-release 40 mg capsules. The award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,882.71 firm fixed-price delivery order is for the supply of 4,564,490,139 units of the medication Duloxetine HCL DR 40 MG Capsules. The contract has an ultimate completion date of May 6, 2024 and was awarded on May 3, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a large...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,839.40 delivery order contract is for the supply of 4566422287 - Duloxetine HCL DR 60 MG Capsules in 90-count packages. The contract has a completion date of November 14, 2024 and was awarded on November 13, 2024 using a firm fixed-price pricing type. This contract is a child vehicle under a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,028.64 Firm Fixed Price Delivery Order is for the supply of 4,562,004,513 units of Duloxetine HCL DR 60 MG capsules. The contract has an ultimate completion date of August 31, 2023 and was awarded on August 30, 2023. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The $9,993.70 firm fixed price delivery order is for the supply of 4,565,564,476 units of Duloxetine Hydrochloride Delayed-Release 60 milligram capsules in 90-count bottles. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,342.68 firm fixed-price delivery order is for the supply of 4,566,692,596 units of Duloxetine HCL DR 40 mg capsules. The award is not designated as a set-aside contract. It is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB25FWSJ3
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,566,824,824 units of Duloxetine HCL DR 40 mg capsules, with a ceiling value of $1,046.01. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of January 3, 2025.

Generated 4/3/25, 10:28 AM